Ifp Advisors, Inc Enanta Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 385 shares of ENTA stock, worth $4,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares

385

Holding current value

$4,161

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$4.26 - $7.95 $1,640 - $3,060	385 New	385 $2,000
Q4 2024 Feb 04, 2025	BUY	$5.75 - $12.99 $17 - $38	3 New	3 $0
Q3 2021 Oct 06, 2021	SELL	$41.02 - $58.65 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$43.76 - $53.11 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$41.69 - $54.95 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$41.16 - $47.47 $10,660 - $12,294	-259 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$43.36 - $53.53 $11,230 - $13,864	259 New	259 $11,000
Q2 2020 Aug 05, 2020	BUY	$46.37 - $57.58 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$40.22 - $62.0 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$57.95 - $66.61 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$60.08 - $88.17 $0 - $0	0 New	0 $0
Q4 2018 Jan 23, 2019	SELL	$65.41 - $84.65 $8,895 - $11,512	-136 Closed	0 $0
Q1 2017 Jun 03, 2019	SELL	N/A	-175 Reduced 56.27%	136 $4,000
Q4 2016 Jun 03, 2019	SELL	N/A	-1,340 Reduced 81.16%	311 $10,000
Q2 2016 Jun 03, 2019	BUY	N/A	1,651	1,651 $36,000

Others Institutions Holding ENTA

# of Institutions

109

Shares Held

18.7M

Call Options Held

50K

Put Options Held

Farallon Capital Management LLC San Francisco, CA

2.12M
Shares

$22.9 Million
0.07% of portfolio
Krensavage Asset Management, LLC New York, NY

2.11M
Shares

$22.9 Million
8.46% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$21.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$20 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.46M
Shares

$15.8 Million
0.01% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $224M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account